Skip to main content
Loading Events

« All Events

  • This event has passed.

Grand Rounds – David E. Nichols, PhD “Psychedelics as Medicines: past, present, and future”

February 27, 2019 @ 8:00 am - 9:00 am

Please join us:

Wednesdays at 8am, Patient Family Resource Center Conference Room (Ground Floor, North Carolina Cancer Hospital)

Hosted by the UNC Comprehensive Cancer Support Program (CCSP) and the UNC Palliative Care Program.

Presenter:     David E. Nichols, PhD


Bio:                 David E. Nichols, PhD is currently an Adjunct Professor of Chemical Biology and Medicinal Chemistry at the University of North Carolina, Chapel Hill, Eshelman School of Pharmacy.  Previously he held the Robert C. and Charlotte P. Anderson Distinguished Chair in Pharmacology and in addition was a Distinguished Professor of Medicinal Chemistry and Molecular Pharmacology at the Purdue University College of Pharmacy, where he taught both professional undergraduate as well as graduate classes.  He also was an Adjunct Professor of Pharmacology and Toxicology at the Indiana University School of Medicine and taught in the medical curriculum.  He received his B.S. degree in chemistry from the University of Cincinnati in 1969, and the PhD in Medicinal Chemistry from the University of Iowa in 1973, following which he did postdoctoral work in pharmacology at the University of Iowa, College of Medicine.  He joined Purdue University in 1974 where he remained until his retirement from Purdue in June 2012.  He was continuously funded by the NIH for nearly three decades and served on numerous government review panels.  His two principal research areas focused on drugs that affect serotonin and dopamine transmission in the CNS.  In 2004 he was named the Irwin H. Page Lecturer by the International Society for Serotonin Research, and in 2006 he received the first Provost’s Outstanding Graduate Mentor award from Purdue University.  He has published more than 300 scientific articles, book chapters, and monographs, most of which deal with the relationship between molecular structure and biological action and has been awarded nine composition of matter patents.  He also serves as a medicinal chemistry expert in patent litigation for major pharmaceutical companies.  In 1993 he founded the Heffter Research Institute, which has supported and funded clinical research with psilocybin and led the so-called “renaissance in psychedelic research.”

Title:               “Psychedelics as Medicines: past, present, and future”

We offer:


The School of Medicine of the University of North Carolina at Chapel Hill is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Continuing Medical Education Statement

The School of Medicine of the University of North Carolina at Chapel Hill designates this live activity for a maximum of 8.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other health professionals will receive a certificate of attendance from an AMA PRA Category 1™ activity. These certificates are accepted by the NC Boards for physician assistants, nurse practitioners, nurses, and respiratory therapists.  Other health care providers may also be able to use these certificates, depending on their particular license requirements.  (License requirements are subject to change. Participants should check with their licensing boards for specific questions.  UNC and its partners are not responsible for changes in license requirements.)

Disclosure statement

This activity has been planned and implemented under the sole supervision of the course director and planning committee, in association with the UNC Office of Continuing Professional Development (UNC CPD).  The course director, planning committee, presenters, and CPD staff have no relevant financial relationships with commercial interests as defined by the ACCME.


February 27, 2019
8:00 am - 9:00 am
Event Category: